Jonathan M. Nugent, VP Corporate Communications at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 285 shares at $7.06 ($2K) on 2007-07-31, disclosed to the SEC on 2007-08-02.
Open-market purchase of $2k BCRX by VP Corporate Communications. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| Filing → |